Pacira Biosciences Up Nearly 12%, On Track for Largest Percent Increase Since November 2020 -- Data Talk

Dow Jones05-08

Pacira Biosciences, Inc. $(PCRX)$ is currently at $29.64, up $3.14 or 11.83%

 

--Would be highest close since March 20, 2024, when it closed at $30.02

--On pace for largest percent increase since Nov. 9, 2020, when it rose 13.73%

--Currently up two consecutive days; up 11.87% over this period

--Best two day stretch since the two days ending Jan. 7, 2021, when it rose 11.89%

--Up 12.93% month-to-date

--Down 12.14% year-to-date

--Down 75.14% from its all-time closing high of $119.27 on Feb. 25, 2015

--Down 30.88% from 52 weeks ago (May 10, 2023), when it closed at $42.89

--Down 30.88% from its 52-week closing high of $42.89 on May 10, 2023

--Up 16.25% from its 52-week closing low of $25.50 on April 25, 2024

--Traded as high as $30.43; highest intraday level since March 13, 2024, when it hit $30.95

--Up 14.79% at today's intraday high; largest intraday percent increase since Nov. 9, 2020, when it rose as much as 15.73%

 

All data as of 10:30:34 AM ET

 

Source: Dow Jones Market Data, FactSet

 

(END) Dow Jones Newswires

May 08, 2024 10:32 ET (14:32 GMT)

Copyright (c) 2024 Dow Jones & Company, Inc.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment